YIH
IRWD icon

Y-Intercept (HK)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Y-Intercept (HK)’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,470
Closed -$47.3K – 1940
2026
Q1 		$47.3K Buy
+13,470
New +$55.2K ﹤0.01% 1483
2025
Q2 		– Sell
-39,782
Closed -$58.5K – 1811
2025
Q1 		$58.5K Buy
39,782
+24,635
+163% +$58.7K ﹤0.01% 1127
2024
Q4 		$67.1K Buy
+15,147
New +$61.5K ﹤0.01% 1114
2024
Q3 		– Sell
-189,962
Closed -$1.24M – 1551
2024
Q2 		$1.24M Buy
189,962
+55,346
+41% +$391K 0.07% 404
2024
Q1 		$1.17M Buy
+134,616
New +$1.63M 0.09% 322
2023
Q3 		– Sell
-33,396
Closed -$355K – 1307
2023
Q2 		$355K Buy
33,396
+4,580
+16% +$49.2K 0.04% 706
2023
Q1 		$303K Buy
+28,816
New +$323K 0.04% 770

Other funds holding IRWD

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
RFG
Range Financial Group Tigard, Oregon $366M AUM 76.17% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Y-Intercept (HK)'s IRWD Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2026, closing a stake of 13,470 shares — an estimated $47.3K sold.

Y-Intercept (HK) first reported a position in IRWD in Q1 2023 and held it in 7 quarters. The position peaked at $1.24M in Q2 2024. 14 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Y-Intercept (HK) reported no remaining Ironwood Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 13,470 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $47.3K.
  • Y-Intercept (HK) first reported a position in Ironwood Pharmaceuticals in Q1 2023 and held it in 7 quarters.
  • Y-Intercept (HK)'s Ironwood Pharmaceuticals position peaked at $1.24M in Q2 2024.
  • 14 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.